KLARON Drug Patent Profile
✉ Email this page to a colleague
When do Klaron patents expire, and what generic alternatives are available?
Klaron is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in KLARON is sulfacetamide sodium. There are three drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Klaron
A generic version of KLARON was approved as sulfacetamide sodium by CHARTWELL RX on October 18th, 1988.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for KLARON?
- What are the global sales for KLARON?
- What is Average Wholesale Price for KLARON?
Summary for KLARON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Patent Applications: | 1,117 |
| Drug Prices: | Drug price information for KLARON |
| What excipients (inactive ingredients) are in KLARON? | KLARON excipients list |
| DailyMed Link: | KLARON at DailyMed |
Pharmacology for KLARON
| Drug Class | Sulfonamide Antibacterial |
US Patents and Regulatory Information for KLARON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch | KLARON | sulfacetamide sodium | LOTION;TOPICAL | 019931-001 | Dec 23, 1996 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
